The store will not work correctly when cookies are disabled.
5-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-methyl-1,3,4-oxadiazol-2-amine
ID: ALA4794879
PubChem CID: 162673578
Max Phase: Preclinical
Molecular Formula: C14H16N4O2
Molecular Weight: 272.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CNc1nnc(CCc2c[nH]c3ccc(OC)cc23)o1
Standard InChI: InChI=1S/C14H16N4O2/c1-15-14-18-17-13(20-14)6-3-9-8-16-12-5-4-10(19-2)7-11(9)12/h4-5,7-8,16H,3,6H2,1-2H3,(H,15,18)
Standard InChI Key: BQFCFEKFFSVPDO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
40.7880 -16.1168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7868 -16.9363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4949 -17.3453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4931 -15.7079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2017 -16.1132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2020 -16.9318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9806 -17.1846 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.4617 -16.5221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9802 -15.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0802 -15.7084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.3726 -16.1171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2325 -15.0828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.0317 -14.9126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2840 -14.1353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0581 -13.8840 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.0578 -13.0668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.2805 -12.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8005 -13.4759 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.0277 -12.0375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.5742 -11.4299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
1 10 1 0
10 11 1 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 1 0
17 19 1 0
19 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 272.31 | Molecular Weight (Monoisotopic): 272.1273 | AlogP: 2.39 | #Rotatable Bonds: 5 |
Polar Surface Area: 75.97 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.93 | CX Basic pKa: ┄ | CX LogP: 1.45 | CX LogD: 1.45 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.75 | Np Likeness Score: -0.95 |
References
1. Herrera-Arozamena C,Estrada-Valencia M,Pérez C,Lagartera L,Morales-García JA,Pérez-Castillo A,Franco-Gonzalez JF,Michalska P,Duarte P,León R,López MG,Mills A,Gago F,García-Yagüe ÁJ,Fernández-Ginés R,Cuadrado A,Rodríguez-Franco MI. (2020) Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties., 190 [PMID:32018096] [10.1016/j.ejmech.2020.112090] |